Corrigendum to "Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells" [Neoplasia 17 (2014) 85].

Autor: Gajula RP; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Chettiar ST; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Williams RD; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Nugent K; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Kato Y; The Russell H. Morgan Department of Radiology and Radiological Science, Division of Cancer Imaging Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; In Vivo Cellular and Molecular Imaging Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Wang H; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Malek R; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Taparra K; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Cellular and Molecular Medicine Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cades J; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Annadanam A; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Yoon AR; Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA., Fertig E; Department of Oncology, Division of Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Firulli BA; Department of Pediatrics, Riley Heart Research Center, Indiana University School of Medicine, Indianapolis, IN, USA., Mazzacurati L; Department of Medicine, Division of Hematology-Oncology, Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Burns TF; Department of Medicine, Division of Hematology-Oncology, Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Firulli AB; Department of Pediatrics, Riley Heart Research Center, Indiana University School of Medicine, Indianapolis, IN, USA., An SS; In Vivo Cellular and Molecular Imaging Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA; Physical Sciences in Oncology Center, Johns Hopkins University, Baltimore, MD, USA; Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA., Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; In Vivo Cellular and Molecular Imaging Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Cellular and Molecular Medicine Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: tranp@jhmi.edu.

Publikováno v: Neoplasia (New York, N.Y.) [Neoplasia] 2024 Nov; Vol. 57, pp. 101010. Date of Electronic Publication: 2024 Jul 11.

The Emerging Role of Immune Checkpoint Blockade for the Treatment of Lung Cancer Brain Metastases.

Autor: Wu X; Department of Medicine, Division of Internal Medicine, University of Pittsburgh, Pittsburgh, PA., Stabile LP; Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA; UPMC Hillman Cancer Center, Pittsburgh, PA., Burns TF; UPMC Hillman Cancer Center, Pittsburgh, PA; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh, Pittsburgh, PA. Electronic address: burnstf@upmc.edu.

Publikováno v: Clinical lung cancer [Clin Lung Cancer] 2024 Sep; Vol. 25 (6), pp. 483-501. Date of Electronic Publication: 2024 Jun 10.

A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).

Autor: Maldonado E; University of California, San Francisco, San Francisco, California., Rathmell WK; Vanderbilt University Medical Center, Nashville, Tennessee., Shapiro GI; Dana-Farber Cancer Institute, Boston, Massachusetts., Takebe N; National Cancer Institute, Bethesda, Maryland., Rodon J; Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas., Mahalingam D; Northwestern University, Evanston, Illinois., Trikalinos NA; Washington University St. Louis, St. Louis, Missouri., Kalebasty AR; University of California, Irvine, Irvine, California., Parikh M; University of California, Davis, Davis, California., Boerner SA; Yale University, New Haven, Connecticut., Balido C; University of California, San Francisco, San Francisco, California., Krings G; University of California, San Francisco, San Francisco, California., Burns TF; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Bergsland EK; University of California, San Francisco, San Francisco, California., Munster PN; University of California, San Francisco, San Francisco, California., Ashworth A; University of California, San Francisco, San Francisco, California., LoRusso P; Yale University, New Haven, Connecticut., Aggarwal RR; University of California, San Francisco, San Francisco, California.

Publikováno v: Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1793-1801.

A Path to Persistence after EGFR Inhibition.

Autor: Rumde PH; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania., Burns TF; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania.; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.

Publikováno v: Cancer research [Cancer Res] 2024 Apr 15; Vol. 84 (8), pp. 1188-1190.

p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.

Autor: Yassin-Kassab A; Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Chatterjee S; Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Khan N; Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Wang N; Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Sandulache VC; Department of Otolaryngology Head and Neck Surgery, Baylor College of Medicine, Houston, TX, USA., Huang EH; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Burns TF; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Duvvuri U; Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. umamaheswar.duvvuri@nyulangone.org.; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. umamaheswar.duvvuri@nyulangone.org.; Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA. umamaheswar.duvvuri@nyulangone.org.; Smilow Research Center, 530 First Avenue, 801.b, New York, NY, 10016, USA. umamaheswar.duvvuri@nyulangone.org.

Publikováno v: BMC cancer [BMC Cancer] 2024 Feb 19; Vol. 24 (1), pp. 233. Date of Electronic Publication: 2024 Feb 19.